ImmunityBio
IBRX
IBRX
60 hedge funds and large institutions have $57.4M invested in ImmunityBio in 2017 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 22 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
60
Holders Change
-8
Holders Change %
-11.76%
% of All Funds
1.5%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
6
Increased
16
Reduced
22
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
BlackRock
New York
|
$7.36M |
| 2 |
2
Renaissance Technologies
New York
|
$1.73M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$7.39M |
| 4 |
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$532K |
| 5 |
5
Barclays
London,
United Kingdom
|
$306K |
